Business Medical Dialogues
    • facebook
    • twitter
    Sign in Signup
    • facebook
    • twitter
    Sign in Signup
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    Sign InRegister
    Business Medical Dialogues
    Sign inRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • 22-member Committee...

    22-member Committee Constituted to guide CDSCO on Medical Device Regulation

    Farhat NasimBy Farhat NasimPublished On 2019-07-27T13:09:11+05:30  |  Updated On 2021-08-16T15:47:48+05:30

    New Delhi: To advice the apex drug regulator, Central Drugs Standard Control Organisation (CDSCO) on matters related to the regulation and implementation of medical devices, the Union Health Ministry has recently constituted a special committee under the name Medical Devices Technical Advisory Group (MDTAG),


    The MDTAG committee will be chaired by Drugs Controller General of India (DCGI) while the Deputy Drugs Controller of India, Medical Devices Division, CDSCO has been appointed as the Member Secretary.


    Besides the Chairperson and the Member Secretary, 22 other members constitute the committee from various departments containing representatives from the following departments;




    • Department of Science and Technology(DST)

    • National Institute of Biologicals (NIB)

    • Indian Council of Medical Research (ICMR)

    • Atomic Energy Regulatory Board (AERB)

    • Defence Research and Development Organisation (DRDO)

    • Bureau of Indian Standards (BIS)

    • IIT, New Delhi

    • Department of Electronics and Information Technology (DEITY)

    • National Health Systems Resource Centre (NHSRC)

    • Association of Diagnostics Manufacturers of India (ADMI)

    • Association of Indian Medical Device Industry (AIMED)

    • Federation of Indian Chambers of Commerce and Industry (FICCI)

    • American Chamber of Commerce in India (AMCHAM India) as its members.


    The committee also has Dr Sandeep Bansal, HOD, Cardiology, VMMC and Safdarjung Hospital, Dr S N Bhattacharya, head, Department of Dermatology, University College of Medical Sciences, New Delhi, Dr Vijay Kumar Jain, associate professor, Department of Orthopaedics, RML Hospital, New Delhi, Dr Arjun Ahuja, head, Seth G S Medical College and KEM Hospital, Mumbai as members.


    Also Read: Johnson and Johnson Faulty Hip Implants: Health Ministry to see that Compensation is paid to patients

    Bringing majority of medical devices under regulation is high on the agenda of the ministry in the second tenure of the Modi government with some incidents of adverse reactions and impacts coming to light with the use of medical devices.


    "The aim is to strengthen the regulations to make medical device companies accountable for quality and safety of their products," a senior official told PTI.


    Recently, global pharma giant Johnson and Johnson (JnJ) was reportedly directed to pay compensation to the patients who received faulty hip implants made by the firm.


    The Union health ministry is already working towards including new provisions to the Drugs and Cosmetics Act to introduce a compensation plan for patients suffering from adverse reactions due to faulty devices or implants.


    "With the approval of the Ministry of Health, it has been decided to constitute a Medical Devices Technical Advisory Group (MDTAG) to advise CDSCO on matters related to the regulation of medical devices.


    "It has been envisaged to examine the issues relating to implementation of Medical Devices Regulations and to suggest CDSCO regarding strengthening of medical devices regulations in the country including Make In India, Ease of doing business etc., and taking up matters with DCC, DTAB and ministry as per requirement," the terms of reference as mentioned in a recent office order stated.


    The meeting will be called by DCGI at least once in four months at CDSCO headquarter.

    (DCC) Advisory Committee CDSCO Central Drugs Standard Control Organisation Department of Dermatology Dr Sandeep Bansal DTAB govt of india JnJ Johnson and Johnson KEM Hospital MDTAG medical device regulation Medical Devices Medical Devices Technical Advisory Group RML hospital Safdarjung Hospital Union Health Ministry VMMC 
    Source : with agency inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

      Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

      Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

      Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

      Delhi HC directs cashless service to all hospitals: GIPSA stayed on Ophthalmological Society petition

      Delhi HC directs cashless service to all hospitals: GIPSA stayed on Ophthalmological Society...

      Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

      Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

      Pharmaceuticals safe in PET packaging: High-level committee

      Pharmaceuticals safe in PET packaging: High-level committee

      Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

      Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

      NPPA fixes prices of 29 formulations under DPCO, check out details

      NPPA fixes prices of 29 formulations under DPCO, check out details

      Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

      Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

      View All

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 29 March 2022 11:15 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
      verify here.

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
      X
      X